74-Year-Old Woman With New-Onset Myoclonus

Zand, Ladan; Hoffman, Scott J.; Nyman, Mark A.
October 2010
Mayo Clinic Proceedings;Oct2010, Vol. 85 Issue 10, p955
Academic Journal
Case Study
The article presents a case study of a 74-year-old female nursing home resident with Alzheimer disease who was admitted to a hospital a five-month history of aggressive behavior. Her medical history includes diagnoses of Alzheimer disease, hypothyroidism, hypertension, and deep venous thromboembolism. Examination of the patient's eye movements showed smooth pursuit with no signs of ocular clonus or nystagmus and that myoclonus and tremor were present in all four limbs.


Related Articles

  • Ifosfamide.  // Reactions Weekly;1/14/2012, Issue 1384, p31 

    The article describes the case of seven patients who developed either negative myoclonus or apostural tremor and encephalopathy during ifosfamide administration.

  • Aggressive seniors focus.  // McKnight's Long-Term Care News;Feb2011, Vol. 32 Issue 2, p22 

    The article discusses the attempt of the Alzheimer's Challenging Behaviors Task Force, a Southern Wisconsin group, to change the way the city of Milwaukee's legal and police departments handle aggressive behavior from older adults.

  • Essential Tremor: Not So Benign? Henchcliffe, Claire // Neurology Alert;Dec2007, Vol. 26 Issue 4, p30 

    THE NEDICES (NEUROLOGICAL DISORDERS IN CENTRAL Spain) survey is a population-based study of age-associated conditions affecting individuals age 65 and older in three communities in central Spain. Baseline evaluations, including a screening question for essential tremor (ET), were completed from...

  • Bringing voice to the next generation information professional. Bertot, John Carlo // Government Information Quarterly;Oct2013, Vol. 30 Issue 4, p528 

    An introduction to articles about reviews of government web sites by the students in the Master of Library Science eGovernment specialization at the University of Maryland is presented.

  • Rivastigmine.  // Reactions Weekly;3/7/2009, Issue 1242, p41 

    The article discusses a case of rivastigmine-induced psychological symptoms. An 82-year-old-man with Alzheimer's diseases became aggressive and hyperactive after taking the drug for eight months. He was diagnosed with obsessional behavior and was treated with citalopram and mianserin. The...

  • Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease. Craig, D; Hart, D J; McCool, K; Mcilroy, S P; Passmore, A P // Journal of Neurology, Neurosurgery & Psychiatry;Sep2004, Vol. 75 Issue 9, p1327 

    The rising number of people with cognitive impairment is placing health care budgets under significant strain. Dementia related behavioural change is a major independent risk factor for admission to expensive institutional care, and aggressive symptoms in particular are poorly tolerated by...

  • A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease. Herrmann, Nathan; Lanctôt, Krista L.; Rothenburg, Lana S.; Eryavec, Goran // Dementia & Geriatric Cognitive Disorders;2007, Vol. 23 Issue 2, p116 

    Background/Aims: To assess the efficacy and tolerability of valproate for the treatment of agitation and aggression in moderate-to-severe Alzheimer’s disease (AD). Methods: This was a randomized, double-blind, placebo-controlled crossover trial of valproate in institutionalized AD...

  • Variant Alzheimer Disease with Spastic Paraparesis: A Rare Presenilin-1 Mutation. Pettersen, Jacqueline A.; Patry, David G.; St.George-Hyslop, Peter H.; Curry, Bernadette // Canadian Journal of Neurological Sciences;Jul2011, Vol. 38 Issue 4, p659 

    The article presents a case study of a 57-year-old woman who died after the course of myoclonus, global cognitive and behavioural changes, and spastic paraperesis. Her myoclonus began for about 15 years before she died while cognitive and behavioural decline were noticed five years before her...

  • Memantine-induced sustained unconsciousness. Kitagawa, Naoyuki; Sakurai, Michio // Neurology & Clinical Neuroscience;Nov2016, Vol. 4 Issue 6, p236 

    Memantine, which is an N-methyl- d-aspartate receptor antagonist, is used for symptomatic treatment of moderate to severe Alzheimer's disease. Here, we present two cases of sustained unconsciousness after the use of memantine. Both cases developed consciousness disturbance after administration...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics